Ledipasvir plus sofosbuvir achieve excellent response in HCV/HIV coinfection

Treatment with ledipasvir and sofosbuvir achieves sustained virologic response at 12 weeks in patients with hepatitis C who also are infected with HIV, according to the results of the open-label...